Open AccessNon-vitamin K antagonist oral anticoagulants therapy for atrial fibrillation patients undergoing electrophysiologic procedures
Author(s) -
Jan Steffel
Publication year - 2020
Publication title -
european heart journal supplements
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.389
H-Index - 36
eISSN - 1554-2815
pISSN - 1520-765X
DOI - 10.1093/eurheartj/suaa102
Subject(s) - medicine , atrial fibrillation , vitamin k antagonist , cardioversion , context (archaeology) , intensive care medicine , antagonist , anesthesia , cardiology , warfarin , paleontology , biology , receptor
Over the last 10 years since the introduction of non-vitamin K antagonist oral anticoagulants (NOACs) into routine clinical practice our experience with these drugs has increased tremendously, also in the context of patients undergoing electrophysiology procedures. While some open questions remain, the available evidence indicates that for the majority of cases, these interventions can safely be performed on NOACs if study-based standard operating procedures are in place and followed. This review summarizes the most current trial evidence and guidelines on the use of NOACs for patients undergoing cardioversion, atrial fibrillation ablation, and device implantations, based on previous work of the author and others.